Jun 28, 2016
MilliporeSigma has entered a research agreement with the International Vaccine Institute (IVI) of Seoul, South Korea to help develop more robust, scalable vaccine manufacturing processes.
|
20160628 |
Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing |